top of page

Suzuki Y. Hypothesis on the Etiology of Skin Complications in Japanese Patients Using Sodium-Glucose Cotransporter 2 Inhibitors .   Clin Med Res. 2017 Mar; 9 (3): 229-230. doi: 10.14740 / jocmr2897w. Epub 2017 Jan 25. No abstract available

Increased Hematocrit During Sodium-Glucose Cotransporter 2 Inhibitor Therapy Indicates Recovery of Tubulointerstitial Function in Diabetic Kidneys. Sano M, Takei M, Shiraishi Y, Suzuki Y. J Clin Med Res. 2016 Dec; 8 (12): 844-847. Epub 2016 Oct 26. Review.

Sano M, Meguro S, Kawai T, Suzuki Y. Increased grip strength with sodium-glucose cotransporter 2 .
J Diabetes. 2016 Sep; 8 (5): 736-7. Doi: 10.1111 / 1753-0407.12402. Epub 2016 Jun 14. No abstract available.

Meguro S, Kawai T, Matsuhashi T, Sano M, Fukuda K, Itoh H, Suzuki Y.   Basal-Supported Oral Therapy with Sitagliptin Counteracts Rebound Hyperglycemia Caused by GLP-1 Tachyphylaxis. J Endocrinol. 2014; 2014: 927317. Doi: 10.1155/2014/927317. Epub 2014 Mar 11.

Matsuhashi T, Sano M, Fukuda K, Kohsaka S, Suzuki Y. Sitagliptin counteracts seasonal fluctuation of glycemic control. J Diabetes . 2012 Jun 15; 3 (6): 118-22. Doi: 10.4239 / wjd.v3.i6.118 ..

Meguro S, Sano M, Kawai T, Matsuhashi T, Mogi S, Fukuda K, Itoh H, Suzuki Y. A new preventive strategy for hypoglycemia incorporated added food diet in patients with type 2 diabetes who received sitagliptin therapy.   Endocr Res . 2012; 37 (4): 175-81. Doi: 10.3109 / 07435800.2012.662664. Epub 2012 May 23

Suzuki Y , Sano M, Hayashida K, Ohsawa I, Ohta S, Fukuda K. Are the effects of alpha-glucosidase inhibitors on cardiovascular events related to elevated levels of hydrogen gas in the gastrointestinal tract ? . FEBS Lett . 2009 Jul 7; 583 (13): 2157-9

Nakashima Y, Ohsawa I, Konishi F, Hasegawa T, Kumamoto S, Suzuki Y, Ohta S. Preventive effects of Chlorella on cognitive decline in age-dependent dementia model mice.
Neurosci Lett . 2009 Oct 30; 464 (3): 193-8.

Fu Y, Ito M, Fujita Y, Ito M, Ichihara M, Masuda A, Suzuki Y , Maesawa S, Kajita Y, Hirayama M, Ohsawa I, Ohta S, Ohno K. Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson's disease. Neurosci Lett. 2009 Apr 3; 453 (2): 81-5.

Ohsawa I, Nishimaki K, Murakami Y, Suzuki Y, Ishikawa M, Ohta S. Age-dependent neurodegeneration accompanying memory loss in transgenic mice defective in mitochondrial aldehyde dehydrogenase 2 activity. J Neurosci. 2008 Jun 11; 28 (24): 6239- 49.

Suzuki Y , Ando F, et al. Association of alcohol dehydrogenase 2 * 1 allele with liver damage and insulin concentration in the Japanese. J Hum Genet . 2006, 51: 31-37

Suzuki Y , Fujisawa M, Ando F, et al. Alcohol dehydrogenase 2 variant is associated with cerebral infarction and lacunae. Neurology (United States), Nov 9 2004, 63 (9) p1711-3

Suzuki Y , Taniyama M, Muramatsu T, et al. ALDH2 / ADH2 polymorphism associated with vasculopathy and neuropathy in type 2 diabetes.
Alcohol Clin Exp Res (United States), Aug 2004, 28 (8 Suppl Proceedings) p111S-116S

Wang D, Taniyama M, Suzuki Y, Katagiri T, Ban Y. Association of the mitochondrial DNA 5178A / C polymorphism with maternal inheritance and onset of type 2 diabetes in Japanese patients. Exp Clin Endocrinol Diabetes Vol. 109: pp. 361-364, 2001

Murata C, Suzuki Y, Muramatsu T, Taniyama M, Atsumi Y, and 3 others. Inactive Aldehyde dehydrogenase 2 worsens glycemic control in patients with type 2 diabetes mellitus who drink low to moderate amounts of alcohol. Alcohol Clin Exp Res Volume 24: 5S Page-11S, 2000

.. Momiyama Y, Suzuki Y. Ohsuzu
F, Atsumi Y, Matsuoka K, and one other person Maternally transmitted susceptibility to non-insulin- dependent diabetes mellitus and left ventricular hypertrophy J Am Coll Cardiol 33 Volume: 1372, pp -1378, 1999

.. Tsukuda K, Suzuki Y,
Kameoka K, Osawa N, Goto Y, and four others Screening of patients with maternally transmitted diabetes for mitochondrial gene mutations in the tRNA region Diabetic Medicine 14 Volume: 1032, pp -1037, 1997

Suzuki Y , Iizuka T, Kobayashi T, Nishikawa T; Atsumi Y; and 7 others. Diabetes mellitus associated with the 3243 mitochondrial tRNA mutation: insulin secretion and sensitivity. Metabolism Vol . 46: pp. 1019-1023, 1997

Suzuki Y , Goto Y, Taniyama M, Nonaka I, Murakami N, and 4 others. Muscle histopathology in diabetes mellitus associated with mitochondrial tRNA mutation at position 3243. Journal of Neurological Sciences 145: 49-53, 1997

Suzuki Y , Taniyama M, Muramatsu T, Atsumi Y, Hosokawa K, and 4 others. Diabetes mellitus associated with 3243 mitochondrial tRNA mutation: Clinical features and coenzyme Q10 treatment. Molec Aspects Med Volume 18: s pp. 181-188, 1997

Suzuki Y , Hosokawa K, Atsumi Y, Matsuoka K. Maternal inherited diabetes is predominant in Japanese and has influence on siblings. Diabetes mellitus: New aspects of pathogenesis and treatment. Eds: T. Kaneko, KB Huh, M. Shichiri, Y. Oka, Smith Gordon , pp. 53-55, 1997

Miyaoka H, Suzuki Y, Taniyama M, Miyaoka Y, Shishikura K, and 3 others. Mental disorders in diabetic patients with mitochondrial transfer RNA mutation at position 3243. Biol Psychiatry Vol. 42: pp. 524-526, 1997

Suzuki Y , Kadowaki H, Atsumi Y, Hosokawa K, Katagiri H, and 6 others. A case of diabetic amyotrophy associated with 3243 mitochondrial tRNA mutation and successful therapy with coenzyme Q10. Endocrine Journal Vol. 42: pp. 144-145, 1995

.. Kadowaki T, Kadowaki H,
Mori Y, Tobe K, Sakuta R, Suzuki Y, other five A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA N Eng J Med 330 Volume: 962 pp - 968 pp, 1994

Suzuki Y. Painless blood sampling for self blood glucose measurement: Lancet Vol. 339: 816-817, 1992
(European Review)

Suzuki Y. Aldehyde dehydrogenase and diabetes mellitus. Focus on diabetic retinopathy Volume 4: 28-33, 1997 (Review)

Suzuki Y, Matsuoka K. Maternal inheritance of diabetes mellitus and diabetic neuropathy. Diabetic neuropathy: new concepts and insights. Eds. Hotta N, Greene DA, et al. Elsevier Science BV : 209 pages-211 pages, 1995

bottom of page